You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ELISpot

Showing 1 - 25 of 1,080
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid 19 Trial in France (patients COVID 19)

Recruiting
  • Covid 19
  • patients COVID 19
  • Antibes, Alpes Maritimes, France
  • +3 more
Feb 18, 2022

Biomarkers Predictive of Severe Forms of COVID-19

Recruiting
  • Covid19
  • ELISPOT
  • QUANTIFERON
  • Saint-Étienne, France
    CHU Saint-Etienne
Mar 10, 2022

Humoral and Cellular Immunity in First-cycle SARS-CoV-2

Completed
  • SARS CoV 2 Infection
  • COVID-19
  • LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)
  • +2 more
  • Catanzaro, Italy
    AOU Mater Domini
Jul 15, 2022

'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell

Completed
  • SARS-CoV-2 Infection
  • SARS-CoV-2 Vaccination
  • Corona-T-test
  • Moscow, Russian Federation
    National Research Center for Hematology
Dec 17, 2021

Cancer Trial in Dijon (serology and ELISPOT test, serology)

Recruiting
  • Cancer
  • serology and ELISPOT test
  • serology
  • Dijon, France
    Centre Georges Francois Leclerc
Mar 24, 2022

Heart Transplant Infection, CMV Infection Trial in Barcelona (ELISPOT IFN-? assay)

Recruiting
  • Heart Transplant Infection
  • CMV Infection
  • ELISPOT IFN-γ assay
  • Barcelona, Spain
    Hospital Universitari de Bellvitge
Dec 22, 2020

Corona Virus Infection Trial in Rouen (ELISPOT)

Recruiting
  • Corona Virus Infection
  • ELISPOT
  • Rouen, France
    Rouen University Hospital
Jan 12, 2021

Kidney Transplant Failure and Rejection Trial in L'Hospitalet de Llobregat, Badalona, Barcelona (biomarkers driven

Recruiting
  • Kidney Transplant Failure and Rejection
  • biomarkers driven immunosuppressive therapy
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +5 more
Jan 7, 2021

Cellular and Humoral Immunity to COVID-19 in Moscow Residents

Recruiting
  • Covid19
  • Respiratory Viral Infection
  • SARS-CoV-2 specific IgM and IgG detection
  • +2 more
  • Moscow, Russian Federation
    Clinical City Hospital named after I.V. Davydovsky of Moscow Dep
May 21, 2021

CMV-specific ELISPOT Assay for Predicting CMV Colitis in

Completed
  • Ulcerative Colitis
  • +2 more
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 14, 2020

    Specific Antibody-secreting Cells in Community-acquired

    Unknown status
    • Community-acquired Pneumonia
    • Specific antibody-secreting cell (ASC) enzyme-linked immunspot (ELISpot) assay
    • Zürich, Switzerland
      University Children's Hospital Zurich
    Nov 11, 2020

    Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • New Haven, Connecticut
      Yale Cancer Center
    Oct 20, 2023

    T-bet B Cells in Persistent Virus Control After Discontinuance

    Completed
    • Chronic HBV Infection
    • Drug Withdrawal
    • T-bet B cell
    • Shanghai, China
      Changhai hospital
    Sep 1, 2023

    Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)

    Recruiting
    • Vaccine-Preventable Diseases
    • +2 more
    • Oral typhoid fever vaccine
    • Oral cholera vaccine
    • Helsinki, Finland
      Meilahti Vaccine Research Center, Helsinki University Hospital
    Oct 27, 2023

    OptiGon - Optimising Laboratory Assays for Immune Responses to

    Not yet recruiting
    • Gonorrhea
    • Blood sample collection
    • Oxford, United Kingdom
      Oxford University Hospitals NHS Foundation Trust
    Nov 15, 2022

    Prostate Cancer Trial in Little Rock (Blood draw)

    Completed
    Has Results
    • Prostate Cancer
    • Blood draw
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 15, 2021

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

    Completed
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Determination of COVID-19 vacciantion efficacy
    • Rouen, France
      Centre Henri Becquerel
    Dec 22, 2022

    Immune Response in Desensitized Patients

    Not yet recruiting
    • Kidney Transplant Rejection
    • Desensitization
    • (no location specified)
    Mar 26, 2023

    Iron Deficiency Anemia Trial in Nairobi (dietary supplement, biological, other)

    Recruiting
    • Iron Deficiency Anemia
    • Iron supplementation
    • +4 more
    • Nairobi, Kenya
      Jomo Kenyatta University Of Agriculture And Technology
    Oct 30, 2023

    Trained Immunity in COVID-19 Vaccinated Individuals

    Recruiting
    • Zoster Varicella
    • Vaccination; Infection
    • recombinant adjuvanted zoster vaccine
    • Wuerzburg, Bavaria, Germany
      University Hospital Wuerzburg
    Jan 26, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

    Not yet recruiting
    • Chronic Hepatitis b
    • Anti-PD-1 Antibody
    • Anti-PD-1 antibody
    • NAs
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 3, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Lyme Disease, Borrelia Infections Trial in Zürich (venous blood puncture)

    Not yet recruiting
    • Lyme Disease
    • Borrelia Infections
    • venous blood puncture
    • Zürich, Switzerland
      Chidren's Hospital Zurich
    Sep 13, 2023

    Immunotherapy, ADR Trial in Beijing

    Not yet recruiting
    • Immunotherapy
    • ADR
      • Beijing, Beijing, China
        Xuanwu Hospital
      Jan 27, 2023

      Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Immune Response of

      Not yet recruiting
      • Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
      • +6 more
      • ChulaCov19 BNA159 mRNA vaccine
      • Bangkok, Thailand
      • +1 more
      Nov 30, 2022